SynthesisBMC medicine2011
Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review.
Synthesis in BMC medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03781895 (Effect of Vitamin D3 on Lung Function and Exercise Tolerance in D3 Deficient COPD Patients), which is not on this map. Cited by 47 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effect of Vitamin D3 on Lung Function and Exercise Tolerance in D3 Deficient COPD Patients
Who cites it
47 citing papers in PubMed.
- Effects of Vitamin D Intake on FEV1 and COPD Exacerbation: A Randomized Clinical Trial Study.Global journal of health science · 2015Trial
- Identification of Five NK Cell-Related Hub Genes in COPD Using Single-Cell RNA Sequencing Analysis.Journal of inflammation research · 2025Article
- Lung transcriptomics reveals the underlying mechanism by which aerobic training enhances pulmonary function in chronic obstructive pulmonary disease.BMC pulmonary medicine · 2024Article
- AI-Supported Comprehensive Detection and Quantification of Biomarkers of Subclinical Widespread Diseases at Chest CT for Preventive Medicine.Healthcare (Basel, Switzerland) · 2022Article
- Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD.NPJ primary care respiratory medicine · 2022Article
- Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.The Lancet. Respiratory medicine · 2021Observational
- Deciphering patterns of respiratory medication use in Ireland to target interventions appropriately: a focus on COPD.Irish journal of medical science · 2021Article
- Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer.Journal of clinical medicine · 2021Review
- Chronic respiratory disease surveys in adults in low- and middle-income countries: A systematic scoping review of methodological approaches and outcomes.Journal of global health · 2021Article
- Targeted therapy in eosinophilic chronic obstructive pulmonary disease.ERJ open research · 2021Review
- Clinico-epidemiological characteristics of men and women with a new diagnosis of chronic obstructive pulmonary disease: a database (SIDIAP) study.BMC pulmonary medicine · 2021Observational
- Prevalence of Asthma and COPD and Blood Eosinophil Count in a Middle-Aged Belgian Population.Journal of clinical medicine · 2019Article
- Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study.International journal of chronic obstructive pulmonary disease · 2019Observational
- Standard expected years of life lost (SEYLL) due to chronic obstructive pulmonary disease (COPD) in Poland from 1999 to 2014.PloS one · 2019Article
- What have we learned from observational studies and clinical trials of mild to moderate COPD?Respiratory research · 2018Review
- Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study.Respiratory research · 2018Observational
- A scoring system to detect fixed airflow limitation in smokers from simple easy-to-use parameters.Scientific reports · 2018Observational
- The physical, mental, and social impact of COPD in a population-based sample: results from the Longitudinal Aging Study Amsterdam.NPJ primary care respiratory medicine · 2018Article
- Cost-Effectiveness of Fixed-Dose Combinations Therapies for Chronic Obstructive Pulmonary Disease Treatment.Clinical drug investigation · 2018Article
- An attempt at modeling COPD epidemiological trends in France.Respiratory research · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic obstructive pulmonary disease (COPD) is predicted to become a major cause of death worldwide. Studies on the variability in the estimates of key epidemiological parameters of COPD may contribute to better assessment of the burden of this disease and to helpful guidance for future research and public policies. In the present study, we examined differences in the main epidemiological characteristics of COPD derived from studies across countries of the European Union, focusing on prevalence, severity, frequency of exacerbations and mortality, as well as on differences between the studies' methods.
methodsThis systematic review was based on a search for the relevant literature in the Science Citation Index database via the Web of Science and on COPD mortality rates issued from national statistics. Analysis was finally based on 65 articles and Eurostat COPD mortality data for 21 European countries.
resultsEpidemiological characteristics of COPD varied widely from country to country. For example, prevalence estimates ranged between 2.1% and 26.1%, depending on the country, the age group and the methods used. Likewise, COPD mortality rates ranged from 7.2 to 36.1 per 10(5) inhabitants. The methods used to estimate these epidemiological parameters were highly variable in terms of the definition of COPD, severity scales, methods of investigation and target populations. Nevertheless, to a large extent, several recent international guidelines or research initiatives, such as GOLD, BOLD or PLATINO, have boosted a substantial standardization of methodology in data collection and have resulted in the availability of more comparable epidemiological estimates across countries. On the basis of such standardization, severity estimates as well as prevalence estimates present much less variation across countries. The contribution of these recent guidelines and initiatives is outlined, as are the problems remaining in arriving at more accurate COPD epidemiological estimates across European countries.
conclusionsThe accuracy of COPD epidemiological parameters is important for guiding decision making with regard to preventive measures, interventions and patient management in various health care systems. Therefore, the recent initiatives for standardizing data collection should be enhanced to result in COPD epidemiological estimates of improved quality. Moreover, establishing international guidelines for reporting research on COPD may also constitute a major contribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.